19
Participants
Start Date
September 11, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Ketone Monoester (KE4)
Each subject will receive beta-hydroxybutyrate boned to R 1,3 Butandiol (KE4) 300mg/kg x 3 for five days. After the treatment period effect variables will be examined.
Placebo
Each subject will receive a placebo drink 3 x day for five days. After the treatment period effect variables will be examined.
RECRUITING
The University Clinic in Nephrology and Hypertension, Gødstrup Region Hospital, Herning
Gødstrup Hospital
OTHER